<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02808234</url>
  </required_header>
  <id_info>
    <org_study_id>Nucel-2015-03</org_study_id>
    <nct_id>NCT02808234</nct_id>
  </id_info>
  <brief_title>Study of Nucel for One and Two Level Lumbar Interbody Fusion</brief_title>
  <official_title>A Single-arm, Prospective, Multi-center Study of Nucel® in Patients Receiving Interbody Fusion for One and Two Level Degenerative Disease of the Lumbar Spine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Organogenesis</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Organogenesis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a prospective non-randomized multi-center feasibility clinical trial to&#xD;
      establish the safety and efficacy of the Nucel® allograft tissue for use in lumbar interbody&#xD;
      fusion procedures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two hundred non-randomized subjects will participate in the study at up to ten clinical sites&#xD;
      in the United States. Participants will be between 18 and 75 years of age. All subjects will&#xD;
      have been established with lumbar spine disease at one or two levels of the lumbar spine that&#xD;
      requires lumbar interbody fusion procedure as per the opinion of the treating surgeon. The&#xD;
      diseases included in the study are spondylosis, degenerative disc disease and&#xD;
      spondylolisthesis. All subjects who meet the inclusion criteria and do not meet the exclusion&#xD;
      criteria and who elect to participate and sign the informed consent will be included in the&#xD;
      study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 2015</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fusion rate using non-contrast CT of the lumbar spine</measure>
    <time_frame>2 years</time_frame>
    <description>Fusion will be assessed 2 years by independent radiologist using alpha-numeric grading scale to quantify bone growth and supplemental fixation quality</description>
  </primary_outcome>
  <other_outcome>
    <measure>Neurologic Exam</measure>
    <time_frame>2 years</time_frame>
    <description>Physician conducted neurological exam</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Analogue Scale</measure>
    <time_frame>2 years</time_frame>
    <description>Patient health outcome survey</description>
  </other_outcome>
  <other_outcome>
    <measure>Oswestry Low Back Pain Disability Index</measure>
    <time_frame>2 years</time_frame>
    <description>Patient health outcome survey</description>
  </other_outcome>
  <other_outcome>
    <measure>SF-12 health survey</measure>
    <time_frame>2 years</time_frame>
    <description>Patient health outcome survey</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Degenerative Disc Disease</condition>
  <condition>Spondylolisthesis</condition>
  <condition>Spondylosis</condition>
  <arm_group>
    <arm_group_label>Nucel treatment group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>One or two level lumbar interbody fusion surgery with Nucel</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>One or two level lumbar interbody fusion surgery</intervention_name>
    <description>One or two level lumbar interbody fusion surgery with allograft derived from human amnion and amniotic fluid.</description>
    <arm_group_label>Nucel treatment group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nucel</intervention_name>
    <description>Allograft derived from human amnion and amniotic fluid</description>
    <arm_group_label>Nucel treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Be between 18 and 75 years of age&#xD;
&#xD;
          2. Have clinical and/or radiological evidence of stenosis, spondylolisthesis, spondylosis&#xD;
             or degenerative disc disease, or at either one or two levels of lumbar spine.&#xD;
&#xD;
          3. In the opinion of the treating surgeon, must already be a qualified candidate for&#xD;
             interbody lumbar fusion surgery with supplemental fixation.&#xD;
&#xD;
          4. Be likely to return for regular follow-ups until the end of the study period.&#xD;
&#xD;
          5. Be willing and able to provide Informed Consent for study participation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Previous lumbar spine fusion surgery at operative level.&#xD;
&#xD;
          2. Back pain due to acute trauma.&#xD;
&#xD;
          3. Clinical, laboratory and/or radiological evidence of back pain secondary to acute or&#xD;
             chronic infection, malignancy, other space occupying lesions and metabolic bone&#xD;
             demineralization diseases (e.g. osteomalacia, gout, Paget's disease etc.)&#xD;
&#xD;
          4. No chronic steroid or chronic prescription NSAID use within three (3) months prior to&#xD;
             surgery.&#xD;
&#xD;
          5. Any active malignancy, infectious process, or documented chronic autoimmune disease.&#xD;
&#xD;
          6. Any other concurrent medical disease or treatment that might impair normal healing&#xD;
             process.&#xD;
&#xD;
          7. Recent history (within past 6 months) of any chemical or alcohol dependence.&#xD;
&#xD;
          8. Morbid obesity (BMI &gt; 40).&#xD;
&#xD;
          9. Currently a prisoner.&#xD;
&#xD;
         10. Currently experiencing a major mental illness (psychosis, schizophrenia, major&#xD;
             affective disorder) which may indicate that the symptoms are psychological rather than&#xD;
             of physical origin.&#xD;
&#xD;
         11. Pregnancy at the time of enrollment or planned pregnancy, which would interfere with&#xD;
             follow-up imaging.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierce Nunley, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spine Institute of Louisiana</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Florida Orthopaedic Insitute</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spine Institute of Louisiana</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina Neurosurgery &amp; Spine</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>June 7, 2016</study_first_submitted>
  <study_first_submitted_qc>June 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2016</study_first_posted>
  <last_update_submitted>May 21, 2021</last_update_submitted>
  <last_update_submitted_qc>May 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
    <mesh_term>Spondylolisthesis</mesh_term>
    <mesh_term>Spondylosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

